MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Identifying Differential DNA Methylation Pathways in Parkinson’s Disease and REM Sleep Behavior Disorder

    Z. Wu, C. Song, J. Ruiz Tejeda, R. Rajmohan, R. Malhas, M. Mapstone, W. Li, N. Phielipp (Irvine, USA)

    Objective: To investigate differential methylation patterns of cell-free DNA (cfDNA) between Parkinson’s Disease (PD), REM Sleep Behavior Disorder (RBD), and Healthy Control (HC) groups. Background:…
  • 2025 International Congress

    Therapeutic Effect and Mechanism of Targeted Nano-selenium in Mouse Model of Parkinson’s Disease Induced by MPTP

    W. Bi, L. Zhu, T. Chen, Y. Cen, J. Zou, Z. Su (Guangzhou, China)

    Objective: In the present study, we developed a nanozyme (Se@PB-ACPP) incorporating selenium-loaded Prussian blue (PB) and modified it with an activatable cell-penetrating peptide (ACPP) to…
  • 2025 International Congress

    The feasibility and practical utility of virtual visits for patients with Parkinson’s disease in different World Regions

    E. Cubo, J. Youn, J. Ahn, O. Ojo, N. Okubadejo, Z. Aldaajani, M. Essam, A. Shalash, A. Garcia, A. Cardozo, M. Spindler, Z. Mari (Burgos, Spain)

    Objective: To compare the access and visit quality/acceptability between in-office and virtual telemedicine visits for patients with Parkinson' s disease (PD) Background: Overcoming existing access…
  • 2025 International Congress

    Analysis of LRRK2 Exonic Variants in Parkinson’s Disease in Chinese Population

    ZY. Qi, YM. Sun, J. Wang (Shanghai, China)

    Objective: To investigate the frequency of multiple LRRK2 variants in Parkinson's disease (PD) cohort, and to explore the effect of LRRK2 variants on the occurrence…
  • 2025 International Congress

    Investigating the Global Genetic Spectrum of Monogenic Parkinson’s Disease and Parkinsonism

    L. Lange, M. Makarious, M. Avenali, S. Bardien, M. Doquenia, C. Galandra, P. Heutink, J. Junker, Y. Kanana, I. Keller Sarmiento, K. Kumar, H. Leonard, K. Levine, SY. Lim, K. Lohmann, N. Mencacci, M. Nalls, AH. Tan, J. Trinh, EM. Valente, C. Blauwendraat, S. Bandres-Ciga, A. Singleton, ZH. Fang, C. Klein (Bethesda, USA)

    Objective: To investigate known pathogenic and risk variants linked to Parkinson’s disease (PD) at a global, multi-ancestry scale. Background: Genetic forms of PD have been…
  • 2025 International Congress

    Returning Secondary Health Findings in the PD GENEration study

    M. Dini, K. Ghosh Galvelis, N. Bothwick, L. Caboy, M. Caulfield, R. de Leon, A. Dilliott, I. Khaderi, S. Rao, A. Yake, A. Coral Zambrano, R. Bhisetti, S. Lawrence, S. Li, Y. Lu, U. Ragunathan, T. Foroud, V. Caceres, L. Cook, K. Fiallos, L. Heathers, R. Hodges, A. Miller, A. Neibaur, M. Rumbaugh, M. Totten, J. Verbrugge, A. Hall, K. Marder, I. Mata, N. Mencacci, M. Nance, T. Simuni, M. Schwarzschild, A. Wills, H. Gao, C. Blauwendraat, J. Beck, R. Alcalay (Miami, USA)

    Objective: To provide secondary health findings (SHF) results to participants enrolled in the PD GENEration study via CLIA genetic testing using whole genome sequencing (WGS)…
  • 2025 International Congress

    A Case for Novel Phenotypes Associated with Digenic CHMP2B-LRRK2 Mutations

    D. Vijaywargiya, T. Chabrashvili (Liverpool, USA)

    Objective: We report a patient presenting with both bv-FTD & PD phenotypes, alongside a complex family history featuring multiple neurodegenerative disorders. Background: The CHMP2B &…
  • 2025 International Congress

    Familial parkinson disease A comparative study between LRRK2 and PINK 1 mutations

    A. Mousli, R. Zouari, Z. Saeid, F. Nabli, A. Rachdi, D. Ben Mohamed, S. Ben Sassi (Tunis, Tunisia)

    Objective: Describe the clinical phenotypes of monogenic forms of PD linked to LRRK2 and PINK1 mutations with a view to a comparative study between the…
  • 2025 International Congress

    Linking Adolescent Brain Development To Parkinson’s Disease Risk Using Machine Learning On Polygenic Risk Scores

    L. Liu, R. Zhu, E. Yu, X. Liu, R. Ge, A. Dagher, Z. Gan-Or (Montreal, Canada)

    Objective: Examine whether adolescent brain structural deviations contribute to Parkinson’s disease (PD) susceptibility. Background: Genetic variants associated with PD have been linked to neurodevelopmental processes,…
  • 2025 International Congress

    Disclosing CLIA certified genetic results within the LARGE-PD Cohort in Peru: Preliminary results of the PD GENEration study

    A. Manrique-Palomino, F. Requejo-Navarro, M. Inca-Martinez, A. Rivera Valdivia, E. Sarapura-Castro, V. Marca, C. Armas, M. Illanes- Manrique, J. Rios-Pinto, K. Mejia-Rojas, A. Medina-Collque, I. Cornejo-Herrera, E. Ochoa-Valle, P. D. Hodges, R. de León, I. F. Mata, M. Cornejo-Olivas (Lima, Peru)

    Objective: To characterize the Peruvian Parkinson’s disease (PD) cohort within the Latin American Research Consortium on the GEnetics of Parkinson Disease (LARGE-PD) that received a…
  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley